Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe cable and Deals have seen settlement amounts in similar cases thru their researching
Does this news have any coreallation with ilns meds or platforms
Does the sec regulate that kind of trading
Isnt it computer generated, matter of timeing on exectution
You are right didn't come from the company, but I did see that info somewhere maybe in an earlier post from the past
Are the invivo studies what dr laferla did in mice and the results were positive
You made this post 5 yrs ago and said it was a maybe and they were leading away from placks you said this in 2011 question is to you why is pifzer in stage 3 trials again with bapi and ponezumabin 2014
You have a gift of putting things into perspective,
Thank you , helps me understand more of wats going on
Merry Christmass
Hard for me to understand why chain left ,All his inventions with ilns
Very promising pipelines,he said big pharma are the envy of ilns pipelines
Then him not owning very much of ilns stock 90,000 shares is nothing.
Cant figure it out
Should be in sec filings
Do you think that's why chain jumped ship
If you look at (avxl) anavex their alzhiemers medicine 2-73 isn't any more promising than bapi or ponezumab, and they are trading at .25 cents ilns has bigger and more promising pipeline in my opinion
Makes a lot of sense, silence is not golden.
hope the court case is the main reason for the silence
Do you think its because ilns really hasn't proven itself yet .
up to this point,they don't have any medicines for fda approval.
Now that viropharma bapi, and ponezumab are back in hunt they are close to success.
big pharma little cautious until they know its a sure thing with one of these trial results
Ive owned it for four years and its never been close to a dollar
Hope 1/8/14 brings us some positive news
Even a small settlement should get us at least to a penny
I guess they see something that looks bright for the future
no problem at least they are thinking positive
Got to start looking at dates.
why are they posting this old news like that.
don't get wat they are trying to accomplish
Click on the article from water 33 post says they favor bapi over solaneuzumab and 50% chance for fda approval,in years time
this is very encoraging
Do you know anything about Anavex 2-73 medicine jst completed stage 1 and moving into stage 2 .
are they ahead of ilns
2014 realy looks bright
We could get news from viropharma
pifzer hearing settlement
toc testing before end of year
news from ponezumab
news from bapi
lonza
possible buyout
and more
future so bright gotta wear shades
Less than three weeks from 01/08/14
Probably one person putting in sell order at .004 then buying it back driving price down to keep it low
I think 2014 is our year ,
pifzer hearing 1/8/14.
toc testing by end of 2014,in humans
and hopefully hear something about viro pharma testingof vp
Theres no losses based on sales of any medicines,
Will settlement be couple mill or hundred mill,
Hey deals , what would be your best guess about how much damage pifzer has done to ilns and how much potenialy they can receive in damages
Could be tax write off sell low now take loss knowing they can buy back cheap next year
wat does this mean for ilns
Must be highschool kids investing their lunch money
Ok im sorry thought lilly bought rights to soley from ilns
If im not mistaken soley came from ilns platform
Ilns has Bapi, Soley ,pone, and viropharma VP currently testing and its only a matter of time
Big pharma is on the sidelines with checkbook and pen in hand ,all we need is one major break through with any of ilns platform medicines then its takeoff
My point is that once any of ilns medicine is in line for fda approval then all of their medicines and platforms will be super valuable everyone knows they only get royalties from viro but the whole theory behind their platforms becomes very saleable
seriously there is a sale for 10,000 shares at .0046 . you would get about 30 dollars after commisions
Viropharma is probably closest medicine in line for fda approval
Cant see big pharma buying ilns till one of medecines in trials is in line for fda approval trials don't bring in money so their not going to pay big money till ilns has something to buy
Tellin Fibs do bar charts really make a difference any positive news can make price change direction in an instant
how can one solely make a decision based on bar charts
Although, settlement will definetly make a difference and give ilns monies to advance pipeline
We might have to wait for results from viropharma testing.
remember bapienzumab, solaneuzumab nothing happened till results came out unfortunately negative then ,
this time hopefully positive .
once big pharma sees positive results then skys the limit